Health Professional Events

Longest Follow-Up Study Finds Ipilimumab Effective in Treating Melanoma

Melanoma is the most dangerous form of skin cancer and the leading cause of deaths due to skin disease. In a new study examining the life expectancy of melanoma patients, researchers found that a particular treatment option called ipilimumab was highly effective. According to the longest, follow-up study, melanoma patients that used ipilimumab can survive up to 10 years.

Read More
MRV News
Melanoma News
Archive
Menu